Delphi-Consensus Weights for Ischemic and Bleeding Events to Be Included in a Composite Outcome for RCTs in Thrombosis Prevention

被引:5
作者
Dechartres, Agnes [1 ,2 ,3 ,4 ]
Albaladejo, Pierre [5 ,6 ]
Mantz, Jean [7 ,8 ]
Samama, Charles Marc [3 ,9 ]
Collet, Jean-Philippe [10 ,11 ]
Steg, Philippe Gabriel [8 ,12 ,13 ]
Ravaud, Philippe [1 ,2 ,3 ,4 ]
Tubach, Florence [1 ,2 ,8 ,14 ,15 ,16 ]
机构
[1] INSERM, UMR S 738, Paris, France
[2] Univ Paris Diderot, UMR S 738, Paris, France
[3] Univ Paris 05, Paris, France
[4] Hop Hotel Dieu, APHP, Ctr Epidemiol Clin, F-75181 Paris, France
[5] Ctr Hosp Univ, Grenoble, France
[6] Univ Grenoble 1, Grenoble, France
[7] Hop Beaujon, APHP, Serv Anesthesie Reanimat & SMUR, Clichy, France
[8] Univ Paris Diderot, Paris, France
[9] Hop Hotel Dieu, APHP, Serv Anesthesie Reanimat, F-75181 Paris, France
[10] Hop La Pitie Salpetriere, Serv Cardiol, Paris, France
[11] Univ Paris 06, F-75252 Paris 05, France
[12] INSERM, U 698, Paris, France
[13] Hop Bichat Claude Bernard, APHP, Serv Cardiol, F-75877 Paris 18, France
[14] INSERM, CIE 801, Paris, France
[15] Hop Bichat Claude Bernard, APHP, Dept Biostat Epidemiol, F-75877 Paris 18, France
[16] Hop Bichat Claude Bernard, APHP, Rech Clin, F-75877 Paris 18, France
来源
PLOS ONE | 2011年 / 6卷 / 04期
关键词
END-POINTS; CARDIOVASCULAR TRIALS; THROMBOLYTIC THERAPY; SELECTION; BENEFITS;
D O I
10.1371/journal.pone.0018461
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Objectives: To weight ischemic and bleeding events according to their severity to be used in a composite outcome in RCTs in the field of thrombosis prevention. Method: Using a Delphi consensus method, a panel of anaesthesiology and cardiology experts rated the severity of thrombotic and bleeding clinical events. The ratings were expressed on a 10-point scale. The median and quartiles of the ratings of each item were returned to the experts. Then, the panel members evaluated the events a second time with knowledge of the group responses from the first round. Cronbach's a was used as a measure of homogeneity for the ratings. The final rating for each event corresponded to the median rating obtained at the last Delphi round. Results: Of 70 experts invited, 32 (46%) accepted to participate. Consensus was reached at the second round as indicated by Cronbach's a value (0.99 (95% CI 0.98-1.00)) so the Delphi was stopped. Severity ranged from under-popliteal venous thrombosis (median = 3, Q1 = 2; Q3 = 3) to ischemic stroke or intracerebral hemorrhage with severe disability at 7 days and massive pulmonary embolism (median = 9, Q1 = 9; Q3 = 9). Ratings did not differ according to the medical specialty of experts. Conclusions: These ratings could be used to weight ischemic and bleeding events of various severity comprising a composite outcome in the field of thrombosis prevention.
引用
收藏
页数:6
相关论文
共 27 条
[11]   A global ranking approach to end points in trials of mechanical circulatory support devices [J].
Felker, G. Michael ;
Anstrom, Kevin J. ;
Rogers, Joseph G. .
JOURNAL OF CARDIAC FAILURE, 2008, 14 (05) :368-372
[12]   Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials [J].
Ferreira-Gonzalez, I. ;
Busse, J. W. ;
Heels-Ansdell, D. ;
Montori, V. M. ;
Akl, E. A. ;
Bryant, D. M. ;
Alonso, J. ;
Jaeschke, R. ;
Schuenemann, H. J. ;
Permanyer-Miralda, G. ;
Domingo-Salvany, A. ;
Guyatt, G. H. .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7597) :786-788A
[13]   Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns [J].
Ferreira-Gonzalez, Ignacio ;
Permanyer-Miralda, Gaieta ;
Busse, Jason W. ;
Bryant, Dianne M. ;
Montori, Victor M. ;
Alonso-Coello, Pablo ;
Walter, Stephen D. ;
Guyatt, Gordon H. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2007, 60 (07) :651-657
[14]   Composite Outcomes Can Distort the Nature and Magnitude of Treatment Benefits in Clinical Trials [J].
Ferreira-Gonzalez, Ignacio ;
Permanyer-Miralda, Gaieta ;
Busse, Jason W. ;
Devereaux, P. J. ;
Guyatt, Gordon H. ;
Alonso-Coello, Pablo ;
Montori, Victor M. .
ANNALS OF INTERNAL MEDICINE, 2009, 150 (08) :566-567
[15]   CONSENSUS METHODS - CHARACTERISTICS AND GUIDELINES FOR USE [J].
FINK, A ;
KOSECOFF, J ;
CHASSIN, M ;
BROOK, RH .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1984, 74 (09) :979-983
[16]   Composite outcomes in randomized trials - Greater precision but with greater uncertainty? [J].
Freemantle, N ;
Calvert, M ;
Wood, J ;
Eastaugh, J ;
Griffin, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (19) :2554-2559
[17]   Interpreting composite outcomes in trials [J].
Freemantle, Nick ;
Calvert, Melanie J. .
BRITISH MEDICAL JOURNAL, 2010, 341
[18]   Evaluation of Comparative Treatment Trials Assessing Clinical Benefits and Risks for Patients, Rather Than Statistical Effects on Measures [J].
Kraemer, Helena Chmura ;
Frank, Ellen .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (06) :683-684
[19]   Composite Outcomes in Cardiovascular Research: A Survey of Randomized Trials [J].
Lim, Eric ;
Brown, Adam ;
Helmy, Adel ;
Mussa, Shafi ;
Altman, Douglas G. .
ANNALS OF INTERNAL MEDICINE, 2008, 149 (09) :612-+
[20]   Validity of composite end points in clinical trials [J].
Montori, VM ;
Permanyer-Miralda, G ;
Ferreira-González, I ;
Busse, JW ;
Pacheco-Huergo, V ;
Bryant, D ;
Alonso, J ;
Akl, EA ;
Domingo-Salvany, A ;
Mills, E ;
Wu, P ;
Schünemann, HJ ;
Jaeschke, R ;
Guyatt, GH .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7491) :594-596